KeyBank National Association’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$671K Sell
6,523
-1,815
-22% -$118K ﹤0.01% 786
2026
Q1
$396K Sell
8,338
-409
-5% -$18.3K ﹤0.01% 919
2025
Q4
$277K Buy
8,747
+1
+0% +$31 ﹤0.01% 1048
2025
Q3
$246K Sell
8,746
-7
-0.1% -$212 ﹤0.01% 1065
2025
Q2
$322K Buy
8,753
+7
+0.1% +$242 ﹤0.01% 957
2025
Q1
$343K Sell
8,746
-1,588
-15% -$71.5K ﹤0.01% 914
2024
Q4
$480K Buy
10,334
+4,691
+83% +$212K ﹤0.01% 800
2024
Q3
$255K Buy
5,643
+1,488
+36% +$70.8K ﹤0.01% 1033
2024
Q2
$205K Buy
+4,155
New +$169K ﹤0.01% 1048
2022
Q2
– Sell
-28,000
Closed -$1.38M – 1122
2022
Q1
$1.38M Buy
+28,000
New +$1.55M 0.01% 434

Other funds holding TWST

KeyBank National Association's TWST Position: Q2 2026 in Review

KeyBank National Association reduced its Twist Bioscience (TWST) stake by 22% in Q2 2026, selling an estimated $118K and leaving 6,523 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

KeyBank National Association first reported a position in TWST in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.38M in Q1 2022. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • KeyBank National Association held 6,523 shares of Twist Bioscience worth $671K as of Q2 2026.
  • KeyBank National Association sold 1,815 Twist Bioscience shares in Q2 2026, an estimated $118K.
  • Twist Bioscience made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #786 holding.
  • KeyBank National Association first reported a position in Twist Bioscience in Q1 2022 and has held it in 10 quarters since.
  • KeyBank National Association's Twist Bioscience position peaked at $1.38M in Q1 2022.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.